US 7611728
Osmotic delivery of therapeutic compounds by solubility enhancement
granted A61KA61K9/0004A61P
Quick answer
US patent 7611728 (Osmotic delivery of therapeutic compounds by solubility enhancement) held by Supernus Pharmaceuticals, Inc. expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K9/0004, A61P, A61P3/10